Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis.

Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis.

Show other versions (1)

<h4>Background</h4>The emergence of drug-resistant Tuberculosis (TB) has made treatment challenging. Although fluoroquinolones (FQs) are used as key drugs in the treatment of multidrug-resistant tuberculosis (MDR-TB), the problem of FQs resistance is becoming increasingly serious. Rifamp...

Full description

Saved in:
Bibliographic Details
Main Authors: Qin Zhou, Na Pu, Ge Xu, Hangchi Liu, Xudong Jia, Xiaomin Wang, Peng Xu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0315512
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items